"Young Adult" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person between 19 and 24 years of age.
| Descriptor ID |
D055815
|
| MeSH Number(s) |
M01.060.116.815
|
| Concept/Terms |
Young Adult- Young Adult
- Adult, Young
- Adults, Young
- Young Adults
|
Below are MeSH descriptors whose meaning is more general than "Young Adult".
Below are MeSH descriptors whose meaning is more specific than "Young Adult".
This graph shows the total number of publications written about "Young Adult" by people in this website by year, and whether "Young Adult" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 71 | 71 |
| 2009 | 0 | 251 | 251 |
| 2010 | 0 | 281 | 281 |
| 2011 | 0 | 303 | 303 |
| 2012 | 0 | 348 | 348 |
| 2013 | 0 | 438 | 438 |
| 2014 | 0 | 454 | 454 |
| 2015 | 0 | 457 | 457 |
| 2016 | 0 | 467 | 467 |
| 2017 | 0 | 445 | 445 |
| 2018 | 0 | 512 | 512 |
| 2019 | 0 | 483 | 483 |
| 2020 | 0 | 417 | 417 |
| 2021 | 0 | 300 | 300 |
| 2022 | 0 | 138 | 138 |
| 2023 | 0 | 141 | 141 |
| 2024 | 0 | 374 | 374 |
| 2025 | 0 | 57 | 57 |
To return to the timeline,
click here.
Below are the most recent publications written about "Young Adult" by people in Profiles.
-
Differentiation of Related Events in Hippocampus Supports Memory Reinstatement in Development. J Cogn Neurosci. 2025 Apr 01; 37(4):853-894.
-
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era. Blood Adv. 2025 Mar 25; 9(6):1356-1365.
-
Comparison of syndromic surveillance and hospital discharge data for unintentional drowning in metropolitan Houston, Texas, USA. Inj Prev. 2025 Mar 20; 31(2):151-157.
-
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma. Clin Cancer Res. 2025 Mar 17; 31(6):975-982.
-
Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
-
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. Blood Adv. 2025 Mar 11; 9(5):955-965.
-
The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States. J Med Econ. 2025 Dec; 28(1):335-345.
-
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers. Haematologica. 2025 Mar 01; 110(3):706-714.
-
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.
-
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy. Blood Adv. 2025 Feb 25; 9(4):783-792.